Cargando…
COVID-19 and Heart: From Clinical Features to Pharmacological Implications
A highly pathogenic human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been recently recognized in Wuhan, China, as the cause of the coronavirus disease 2019 (COVID-19) outbreak which has spread rapidly from China to other countries in the world, causing a pandemic...
Autores principales: | Russo, Vincenzo, Bottino, Roberta, Carbone, Andreina, Rago, Anna, Papa, Andrea Antonio, Golino, Paolo, Nigro, Gerardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355803/ https://www.ncbi.nlm.nih.gov/pubmed/32580344 http://dx.doi.org/10.3390/jcm9061944 |
Ejemplares similares
-
Echocardiographic Features of Cardiac Involvement in Myotonic Dystrophy 1: Prevalence and Prognostic Value
por: Russo, Vincenzo, et al.
Publicado: (2023) -
The Effect of Sacubitril/Valsartan on Device Detected Arrhythmias and Electrical Parameters among Dilated Cardiomyopathy Patients with Reduced Ejection Fraction and Implantable Cardioverter Defibrillator
por: Russo, Vincenzo, et al.
Publicado: (2020) -
Prevalence and clinical predictors of inappropriate direct oral anticoagulant dosage in octagenarians with atrial fibrillation
por: Carbone, Andreina, et al.
Publicado: (2022) -
Direct Current Cardioversion in Atrial Fibrillation Patients on Edoxaban Therapy Versus Vitamin K Antagonists: a Real-world Propensity Score–Matched Study
por: Rago, Anna, et al.
Publicado: (2020) -
Cardiac resynchronization improves
heart failure in one patient with Myotonic
Dystrophy type 1. A case report
por: RUSSO, VINCENZO, et al.
Publicado: (2012)